MGF
MGF
No registered human study names MGF as an intervention. ClinicalTrials.gov holds no trial of it, so there is no trial evidence to read — a fact about the public record rather than proof the compound does nothing. No FDA-approved product contains MGF. 772 papers naming it were published in the last ten years.
Collected 2026-08-02 from ClinicalTrials.gov and Drugs@FDA. Counts include only trials whose registered intervention names MGF; the registry search is fuzzy, so every match is re-checked. None of this says whether MGF works or is safe.
FDA status
Research only
Human studies
0
Furthest phase
—
Papers, 10 yr
772
Readership
597
monthly average, Feb–Jul 2026
Tracking since 2026-07-29 · About this data
What has actually been tested in humans
No registered human study
0
Registered human studies
None
No FDA-approved product contains it
102 loose registry matches were checked and 0 confirmed — 102 named something else and were discarded. We count a study only when MGF is named as an intervention in it.
No study of MGF in humans is registered on ClinicalTrials.gov. That is a fact about the public record, not a statement that the compound does nothing — but it does mean there is no trial evidence to read, and anyone telling you otherwise should be asked for the registration number. The grade is mechanical: it is computed from the registry and the FDA record alone, and it grades how much is known, never whether a compound is good or safe. Collected 2026-08-02 from ClinicalTrials.gov and Drugs@FDA. Check the query.
What MGF is, and what it has been studied for
MGF is tracked here.
No registered trial names MGF as an intervention, so there is no condition it has been formally studied in. It does have a literature: 772 indexed papers name it in the last ten years. That work is laboratory and animal research, and a paper is not a trial.
Is anyone studying MGF?
Papers published each year that name MGF in the title or abstract, with the clinical trials that started in the same year marked beneath. Ten calendar years.
| Year | Publications | Trials started | Complete year |
|---|---|---|---|
| 2017 | 67 | 0 | Yes |
| 2018 | 51 | 0 | Yes |
| 2019 | 67 | 0 | Yes |
| 2020 | 78 | 0 | Yes |
| 2021 | 89 | 0 | Yes |
| 2022 | 115 | 0 | Yes |
| 2023 | 91 | 0 | Yes |
| 2024 | 91 | 0 | Yes |
| 2025 | 100 | 0 | Yes |
| 2026 | 81 | 0 | No |
772 papers between 2017 and 2026. A paper counts when “MGF” appears in its title or abstract — phrase-matched, so a paper mentioning the words separately is not counted. The total is a single query over the whole window, which is why it does not equal the bars added together: PubMed files a paper under both its electronic and its print publication date, so one paper can appear in two years. Publication volume measures scientific attention, not whether a compound works: a well-studied compound can be well-studied and ineffective. Sources: PubMed and ClinicalTrials.gov · collected 2026-08-02.
Published research on MGF
772 indexed papers name MGF in their title or abstract. These are the 8 PubMed ranks most relevant. Listing a paper is not a judgement about it, and none of these is summarised here — follow the link and read what it says.
- African swine fever virus MGF_110-3L and MGF_110-4L signal TLR2-mediated lethal inflammation
- MgF(2):Mn(2+): novel material with mechanically-induced luminescence
- Mechanochemical coupling of MGF mediates periodontal regeneration
- African Swine Fever Virus MGF 360-2L Disrupts Host Antiviral Immunity Based on Transcriptomic Analysis
- The African swine fever virus gene MGF_360-4L inhibits interferon signaling by recruiting mitochondrial selective autophagy receptor SQSTM1 degrading MDA5 antagonizing innate immune responses
- Growth factors and muscle ageing
- Involvement of the MGF 110-11L Gene in the African Swine Fever Replication and Virulence
- Intraoperative graft verification in coronary surgery
Collected 2026-08-02from PubMed, phrase-matched on “MGF” in title and abstract. Run the same search.
Reading on this compound
All articles →PepRack articles that reference this compound. This is not a news feed — we syndicate nothing and publish no datelines.
Vendor listings are not affiliate links and PepRack earns nothing from them. A listing records a price we observed on a date. It is not a recommendation of a product, dose, or treatment, and PepRack does not verify what any vendor ships.